论文信息 - ICON8: A GCIG phase III randomised trial evaluating weekly dosedense chemotherapy integration in first- line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis - 字舞流文

ICON8: A GCIG phase III randomised trial evaluating weekly dosedense chemotherapy integration in first- line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis

J. Brenton | J. Ledermann | I. McNeish | R. Kaplan | A. Clamp | T. Perren | S. Stenning | S. Blagden | A. Swart | S. Sundar | C. Coyle | A. Dean | A. Cook | R. Naik | D. Gallardo | D. O'Donnell | J. Hook | E. James | Jonathan A. Ledermann | J. Weon-Kim